Search Results - "RUZZENE, Maria"

Refine Results
  1. 1

    Role of protein kinase CK2 in antitumor drug resistance by Borgo, Christian, Ruzzene, Maria

    “…Drug resistance represents the major reason of pharmacological treatment failure. It is supported by a broad spectrum of mechanisms, whose molecular bases have…”
    Get full text
    Journal Article
  2. 2

    Protein kinase CK2: a potential therapeutic target for diverse human diseases by Borgo, Christian, D’Amore, Claudio, Sarno, Stefania, Salvi, Mauro, Ruzzene, Maria

    Published in Signal transduction and targeted therapy (17-05-2021)
    “…CK2 is a constitutively active Ser/Thr protein kinase, which phosphorylates hundreds of substrates, controls several signaling pathways, and is implicated in a…”
    Get full text
    Journal Article
  3. 3

    Addiction to protein kinase CK2: A common denominator of diverse cancer cells? by Ruzzene, Maria, Pinna, Lorenzo A.

    Published in Biochimica et biophysica acta (01-03-2010)
    “…At variance with most oncogenic protein kinases whose malignancy is generally due to genetic alterations conferring constitutive activity, CK2 is a highly…”
    Get full text
    Journal Article
  4. 4

    Casein kinase: the triple meaning of a misnomer by Venerando, Andrea, Ruzzene, Maria, Pinna, Lorenzo A

    Published in Biochemical journal (01-06-2014)
    “…The term 'casein kinase' has been widely used for decades to denote protein kinases sharing the ability to readily phosphorylate casein in vitro. These fall…”
    Get more information
    Journal Article
  5. 5

    The selectivity of inhibitors of protein kinase CK2: an update by Pagano, Mario A, Bain, Jenny, Kazimierczuk, Zygmunt, Sarno, Stefania, Ruzzene, Maria, Di Maira, Giovanni, Elliott, Matthew, Orzeszko, Andrzej, Cozza, Giorgio, Meggio, Flavio, Pinna, Lorenzo A

    Published in Biochemical journal (01-11-2008)
    “…CK2 (casein kinase 2) is a very pleiotropic serine/threonine protein kinase whose abnormally high constitutive activity has often been correlated to…”
    Get more information
    Journal Article
  6. 6

    Targeting CK2 in cancer: a valuable strategy or a waste of time? by Salvi, Mauro, Borgo, Christian, Pinna, Lorenzo A., Ruzzene, Maria

    Published in Cell death discovery (29-10-2021)
    “…CK2 is a protein kinase involved in several human diseases (ranging from neurological and cardiovascular diseases to autoimmune disorders, diabetes, and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells by Alcaraz, Estefania, Vilardell, Jordi, Borgo, Christian, Sarró, Eduard, Plana, Maria, Marin, Oriano, Pinna, Lorenzo A, Bayascas, José R, Meseguer, Anna, Salvi, Mauro, Itarte, Emilio, Ruzzene, Maria

    Published in PloS one (01-01-2020)
    “…The PI3K/Akt pathway is interconnected to protein kinase CK2, which directly phosphorylates Akt1 at S129. We have previously found that, in HK-2 renal cells,…”
    Get full text
    Journal Article
  9. 9

    Helicobacter pylori periplasmic receptor CeuE (HP1561) modulates its nickel affinity via organic metallophores by Shaik, Md Munan, Cendron, Laura, Salamina, Marco, Ruzzene, Maria, Zanotti, Giuseppe

    Published in Molecular microbiology (01-02-2014)
    “…Summary In Gram‐negative bacteria, nickel uptake is guaranteed by multiple and complex systems that operate at the membrane and periplasmic level. Helicobacter…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity by Cozza, Giorgio, Zanin, Sofia, Sarno, Stefania, Costa, Elena, Girardi, Cristina, Ribaudo, Giovanni, Salvi, Mauro, Zagotto, Giuseppe, Ruzzene, Maria, Pinna, Lorenzo A

    Published in Biochemical journal (01-11-2015)
    “…By derivatizing the purely competitive CK2 inhibitor N1-(4,5,6,7-tetrabromo-1H-benzimidazol-2-yl)-propane-1,3-diamine (K137) at its 3-amino position with a…”
    Get more information
    Journal Article
  13. 13

    The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells by Di Maira, Giovanni, Gentilini, Alessandra, Pastore, Mirella, Caligiuri, Alessandra, Piombanti, Benedetta, Raggi, Chiara, Rovida, Elisabetta, Lewinska, Monika, Andersen, Jesper B., Borgo, Christian, Salvi, Mauro, Ottaviani, Daniele, Ruzzene, Maria, Marra, Fabio

    Published in Oncogenesis (New York, NY) (22-10-2019)
    “…Cholangiocarcinoma (CCA) is a particularly aggressive hepatobiliary malignancy, for which the molecular mechanisms underlying the malignant phenotype are still…”
    Get full text
    Journal Article
  14. 14

    The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131 by Vilardell, Jordi, Girardi, Cristina, Marin, Oriano, Cozza, Giorgio, Pinna, Lorenzo A, Ruzzene, Maria

    Published in PloS one (01-03-2018)
    “…CK2 is a pleiotropic S/T protein kinase (formerly known as casein kinase 2) which is attracting increasing interest as therapeutic target, and the…”
    Get full text
    Journal Article
  15. 15

    Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells by Zanin, Sofia, Borgo, Christian, Girardi, Cristina, O'Brien, Sean E, Miyata, Yoshihiko, Pinna, Lorenzo A, Donella-Deana, Arianna, Ruzzene, Maria

    Published in PloS one (08-11-2012)
    “…CK2 is a pleiotropic protein kinase, which regulates many survival pathways and plays a global anti-apoptotic function. It is highly expressed in tumor cells,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Synthesis and properties of a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2) by Cozza, Giorgio, Zanin, Sofia, Determann, Renate, Ruzzene, Maria, Kunick, Conrad, Pinna, Lorenzo A

    Published in PloS one (24-02-2014)
    “…Homeodomain-interacting protein kinase 2 (HIPK2) is a Ser/Thr kinase controlling cell proliferation and survival, whose investigation has been hampered by the…”
    Get full text
    Journal Article
  18. 18

    Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells by Kreutzer, Jan N, Ruzzene, Maria, Guerra, Barbara

    Published in BMC cancer (19-08-2010)
    “…Pancreatic cancer is a complex genetic disorder that is characterized by rapid progression, invasiveness, resistance to treatment and high molecular…”
    Get full text
    Journal Article
  19. 19

    Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells by Di Maira, Giovanni, Brustolon, Francesca, Pinna, Lorenzo A., Ruzzene, Maria

    “…Akt (PKB) is a critical kinase in cell-survival pathways. Its activity depends on the phosphorylation of Thr308 and Ser473, by PDK1 and mTORC2, respectively…”
    Get full text
    Journal Article
  20. 20

    Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells by Ruzzene, Maria, Penzo, Daniele, Pinna, Lorenzo A

    Published in Biochemical journal (15-05-2002)
    “…Incubation of Jurkat cells with 4,5,6,7-tetrabromobenzotriazole (TBB), a specific inhibitor of protein kinase CK2, induces dose-and time-dependent apoptosis as…”
    Get full text
    Journal Article